Jane Street Group, LLC Eye Point Pharmaceuticals, Inc. Transaction History
Jane Street Group, LLC
- $445 Billion
- Q3 2024
A detailed history of Jane Street Group, LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 42,586 shares of EYPT stock, worth $446,727. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,586
Previous 101,787
58.16%
Holding current value
$446,727
Previous $885,000
61.58%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding EYPT
# of Institutions
150Shares Held
58MCall Options Held
177KPut Options Held
263K-
Cormorant Asset Management, LP Boston, MA8.33MShares$87.3 Million4.66% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.18MShares$54.3 Million1.63% of portfolio
-
Franklin Resources Inc San Mateo, CA4.01MShares$42.1 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.79MShares$39.8 Million0.06% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$39.5 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $357M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...